Compass Financial Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.4K Buy
300
+2
+0.7% +$92 ﹤0.01% 1097
2026
Q2
$13.2K Buy
+298
New +$12.8K ﹤0.01% 996

Other funds holding NVO

Compass Financial Management's NVO Position: Q3 2026 in Review

Compass Financial Management increased its Novo Nordisk (NVO) stake by 0.67% in Q3 2026, buying an estimated $92 and bringing the position to 300 shares worth $11.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1097.

Compass Financial Management first reported a position in NVO in Q2 2026 and has held it in 2 quarters since. The position peaked at $13.2K in Q2 2026. 1,232 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Compass Financial Management held 300 shares of Novo Nordisk worth $11.4K as of Q3 2026.
  • Compass Financial Management bought 2 Novo Nordisk shares in Q3 2026, an estimated $92.
  • Novo Nordisk made up ﹤0.01% of Compass Financial Management's portfolio in Q3 2026, its #1097 holding.
  • Compass Financial Management first reported a position in Novo Nordisk in Q2 2026 and has held it in 2 quarters since.
  • Compass Financial Management's Novo Nordisk position peaked at $13.2K in Q2 2026.
  • 1,232 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Compass Financial Management's 13F filing for Q3 2026, filed 30 Oct 2026.